Area of research
Immunology · Oncology
Research interest
Research interests include Immune Cell Function and Interaction, T-cell and B-cell Immunology, CAR-T cell therapy research, and Hepatitis B Virus Studies.
αTIGIT-IL2 achieves tumor regression by promoting tumor-infiltrating regulatory T cell fragility in mouse models
Advances in SERS technology for molecular immunophenotyping
ROTACs leverage signaling-incompetent R-spondin for targeted protein degradation
Uncoupling the BMP receptor antagonist function from the WNT agonist function of R-spondin 2 using the inhibitory peptide dendrimer RWd
ROTACs leverage signaling-incompetent R-spondin for targeted protein degradation
METTL3-mediated m6A RNA methylation promotes the anti-tumour immunity of natural killer cells
RSPO2 inhibits BMP signaling to promote self-renewal in acute myeloid leukemia
R-spondins are BMP receptor antagonists in Xenopus early embryonic development
R-spondins are BMP receptor antagonists in early embryonic development
Exploring the molecular mechanism of the effect of puerarin on P2X3
Oncofetal gene SALL4 reactivation by hepatitis B virus counteracts miR-200c in PD-L1-induced T cell exhaustion
Association of decreased expression of the macrophage scavenger receptor MARCO with tumor progression and poor prognosis in human hepatocellular carcinoma
Contribution of inhibitory receptor TIGIT to NK cell education
High NKG2A expression contributes to NK cell exhaustion and predicts a poor prognosis of patients with liver cancer
Differential phenotypic and functional properties of liver-resident NK cells and mucosal ILC1s
Liver-resident NK cells confer adaptive immunity in skin-contact inflammation
Natural killer cells promote immune tolerance by regulating inflammatory T <sub>H</sub> 17 cells at the human maternal–fetal interface